La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Modular Medical a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Modular Medical..

Modular Medical (NASDAQ:MODD) Azioni, Catena delle Opzioni

Modular Medical

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

Modular Medical Inc

<p>Funko (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.04 by 250 percent. This is a 366.67 percent increase over earnings of $0.03 per share from the same period last year.  The company reported quarterly sales of $292.765 million which beat the analyst consensus estimate of $289.601 million by 1.09 percent.  This is a 6.45 percent decrease over sales of $312.944 million the same period last year.</p>


Earnings

Earnings Beats

News

FNKO

Funko Q3 2024 Adj. EPS $0.14 Beats $0.04 Estimate, Sales $292.765M Beat $289.601M Estimate

<p>System1 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SST#NYSE">SST</a>) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.29) by 17.24 percent.  The company reported quarterly sales of $88.832 million which beat the analyst consensus estimate of $86.629 million by 2.54 percent.  This is a 1.15 percent increase over sales of $87.818 million the same period last year.</p>


Earnings Misses

System1 Q3 2024 GAAP EPS $(0.34) Misses $(0.29) Estimate, Sales $88.832M Beat $86.629M Estimate

<p>Mexco Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) reported quarterly earnings of $0.15 per share. This is a 25 percent increase over earnings of $0.12 per share from the same period last year.  The company reported $1.75 million in sales this quarter. This is a 24.32 percent increase over sales of $1.41 million the same period last year.</p>


Mexco Energy Q2 EPS $0.15 Up From $0.12 YoY, Sales $1.75M Up From $1.41M YoY

WIIM

QDEL

QuidelOrtho shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 revenue above estimates.

RXST

RxSight shares are trading lower. The company reported Q3 financial results.

EPRX

Eupraxia Pharmaceuticals Reports Q3 Net Income Of $(6.0)M, Down From $(4.9)M Loss Last Year

<p>TELA Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELA#NASDAQ">TELA</a>) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.41) by 2.44 percent. This is a 6.67 percent increase over losses of $(0.45) per share from the same period last year.  The company reported quarterly sales of $18.957 million which beat the analyst consensus estimate of $18.852 million by 0.56 percent.  This is a 25.94 percent increase over sales of $15.052 million the same period last year.</p>


TELA

TELA Bio Q3 2024 GAAP EPS $(0.42) Misses $(0.41) Estimate, Sales $18.957M Beat $18.852M Estimate

Tuscows Q3 Revenue $92.297M Up From 86.971M YoY

LCID

Lucid Group shares are trading higher after the company reported better-than-expected Q3 financial results.

<p>Puma Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBYI#NASDAQ">PBYI</a>) .</p>


Guidance

PBYI

Puma Biotechnology expects Q424 Net Product Revenue: $46M-$48M; FY2024: $187M-$190M (Prev. $183M-$190M).

KTOS

Kratos Defense & Security shares are trading lower after the company reported worse-than-expected Q3 revenue results.

Offerings

Valley National Bancorp Announces Proposed Common Stock Offering

<p>Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.08 by 112.5 percent.  The company reported quarterly sales of $330.399 million which missed the analyst consensus estimate of $382.239 million by 13.56 percent.  This is a 17.46 percent decrease over sales of $400.268 million the same period last year.</p>


Bloom Energy Q3 2024 Adj. EPS $(0.01) Misses $0.08 Estimate, Sales $330.399M Miss $382.239M Estimate

<p>Chesapeake Utilities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPK#NYSE">CPK</a>) affirms FY2025 GAAP EPS guidance from $6.15-6.35 to $6.15-6.35 vs $6.25 analyst estimate..</p>


Chesapeake Utilities Affirms FY2025 GAAP EPS Guidance from $6.15-6.35 to $6.15-6.35 vs $6.25 Est

CPRI

Capri Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results.

<p>Chesapeake Utilities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPK#NYSE">CPK</a>) affirms FY2024 GAAP EPS guidance from $5.33-5.45 to $5.33-5.45 vs $5.39 analyst estimate..</p>


Chesapeake Utilities Affirms FY2024 GAAP EPS Guidance from $5.33-5.45 to $5.33-5.45 vs $5.39 Est

Buybacks

TRIN

Trinity Capital Inc. Announces Stock Repurchase Program Of Up To $30M

FLYW

Flywire shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 revenue guidance above estimates.

<p>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) reported quarterly losses of $(0.40) per share which met the analyst consensus estimate. This is a 18.37 percent increase over losses of $(0.49) per share from the same period last year.</p>


Vor Biopharma Q3 EPS $(0.40), Inline

Ovintiv Sees FY24 Capital Investment $2.275B-$2.325B

Modular Medical drops 7%, prices $10M share offering

Modular Medical Inc (MODD) is down -3.20%% today. MODD has an Overall Score of 14. Find out what this means to you and get the rest of the rankings on MODD!See Full MODD ReportMODD stock closed at $1.25 and is down -$0.04 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as m

Should You Accumulate Modular Medical Inc (MODD) Stock Friday Morning?

Modular Medical (MODD) has released an update. Modular Medical, Inc. has struck a deal with Titan Partners Group for a firm commitment offering of ...

Modular Medical Secures $10M Deal with Titan Partners

The market has been high on Modular Medical Inc (MODD)  stock recently. MODD gets a Bullish score from InvestorsObserver Stock Sentiment Indicator. Modular Medical Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on MODD!See Full MODD ReportWhat is Stock Sentiment?When

Is Modular Medical Inc (MODD) Stock About to Get Hot Friday?

Modular Medical, Gryphon Digital Mining to join Russell Microcap Index

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Modular Medical</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/modd-stock-quote/"><strong>MODD</strong></a></span>) just reported results for the fourth quarter of 2024.</p><ul><li>Modular Medical reported earnings per share of -14 cents. This was above the analyst estimate for EPS of -17 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/06/modd-stock-earnings-modular-medical-for-q4-of-2024/">MODD Stock Earnings: Modular Medical Beats EPS for Q4 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

MODD Stock Earnings: Modular Medical Beats EPS for Q4 2024

Modular Medical initiates transfer of manufacturing operations to Phillips Medisize

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Modular Medical</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/modd-stock-quote/"><strong>MODD</strong></a></span>) just reported results for the first quarter of 2025.</p><ul><li>Modular Medical reported earnings per share of -12 cents. This was above the analyst estimate for EPS of -20 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/modd-stock-earnings-modular-medical-for-q1-of-2025/">MODD Stock Earnings: Modular Medical Beats EPS for Q1 2025</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

MODD Stock Earnings: Modular Medical Beats EPS for Q1 2025

Modular Medical (MODD) has provided an announcement. Modular Medical, Inc. introduced a Bonus Program to motivate its employees with stock options ...

Modular Medical Incentivizes FDA Milestones with Stock Options

Modular Medical reports issuance of U.S. patent covering key aspects of core pumping technology

GRYP

MODD

Press Releases

Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump

Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump

Growth Stocks Across Multiple Sectors-Innovators in Action: MODD, INBS, RCAT, KAVL, WHLR"

Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform

Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology

Events

Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1

Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX

New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH)

Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study

Biotech and Technology Giants Drive Innovation Across Pharma, Medical Devices, and Industrial Automation CRDL, MODD, CYN

ACXP

CRDL

DBVT

INBS

KAVL

LPTH

NVDA

PRSO

RCAT

SGTM

SWISF

TSX:CRDL

VRAX

WHLR

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment

HeartBeam

CytoSorbents

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Alpha Tau Medical

Daxor

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

Modular Medical

Modular Medical (MODD) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO